Asahi Kasei, GlaxoSmithKline and Johnson & Johnson helped the respiratory disease drug developer boost its overall funding to $150m.

Wiz, the developer of a cyber risk analytics platform, has reportedly secured new funding in a Salesforce-led round that is its third in six months.

Bascom Palmer Eye Institute’s spinout is working on AR/VR vision diagnosis and augmentation technology and has secured more cash five months after its seed funding.

Main Sequence Ventures-backed Amber has closed a $15.5m series B round led by Commonwealth Bank.

IP Group has participated in a $92m series C round for Pulmocide, a developer of treatments for respiratory diseases that was spun out of Imperial College London.

Affirm spinoff Resolve raised $60m from investors including its parent company, while sales and marketing software provider Qualified secured $51m in a Salesforce-backed round.

Columbia has taken an equity stake in the antiviral therapeutics producer, co-founded by two of its faculty members.

PreSeed Ventures-backed Pento has secured $15.6m in a series A round led by General Catalyst, bringing its total financing to $19.1m.

Respective endowments for University of Macau and Macau University of Science and Technology have contributed to a series A round.

CU Boulder spinout ColdQuanta has now raised $74m in funding altogether, having previously obtained $32m in a series A round six months ago.